Lars Viktrup

6.4k citations

151 papers · 4.6k indexed · h-index 39

Impact in

Urology top 0.05%
- Urinary Bladder and Prostate Research
Rheumatology top 0.2%
- Pelvic floor disorders treatments
- Osteoarthritis Treatment and Mechanisms

Papers in ⓘ

Urology 60
- Urinary Bladder and Prostate Research 60
Rheumatology 71
- Pelvic floor disorders treatments 43
- Osteoarthritis Treatment and Mechanisms 28

Co-authors: Gunnar Lose (13 shared papers)Claus G. Roehrborn (12 shared papers)Albert Elion‐Mboussa (8 shared papers)Kevin T. McVary (6 shared papers)François Giuliano (4 shared papers)Lei Xu (4 shared papers)Ilker Yalcin (6 shared papers)David A. Cox (6 shared papers)
Journals: The Journal of Urology (7 papers)Current Medical Research and Opinion (6 papers)British Journal of Urology (6 papers)European Urology (6 papers)Osteoarthritis and Cartilage (6 papers)
Partner nations: United States United Kingdom Denmark

In The Last Decade

Lars Viktrup

144 papers receiving 4.5k citations

Peers

Countries citing papers authored by Lars Viktrup

Since Specialization

Citations

This map shows the geographic impact of Lars Viktrup's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Viktrup with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Viktrup more than expected).

Fields of papers citing papers by Lars Viktrup

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Viktrup. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Viktrup. The network helps show where Lars Viktrup may publish in the future.

Co-authors

The 25 scholars most cited alongside Lars Viktrup, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lars Viktrup Line = papers co-authored together Lars Viktrup links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 151 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The symptom of stress incontinence caused by pregnancy or delivery in primiparas. PubMed ·Lars Viktrup, Gunnar Lose, M Rolff, K. Barfoed	1992	242
2	Monotherapy with Tadalafil or Tamsulosin Similarly Improved Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia in an International, Randomised, Parallel, Placebo-Controlled Clinical Trial European Urology ·Matthias Oelke, François Giuliano, Vincenzo Mirone, Lei Xu, David A. Cox, Lars Viktrup	2012	224
3	Tadalafil Administered Once Daily for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Dose Finding Study The Journal of Urology ·Claus G. Roehrborn, Kevin T. McVary, Albert Elion‐Mboussa, Lars Viktrup	2008	213
4	Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: Pathophysiology and mechanism(s) of action Neurourology and Urodynamics ·Karl‐Erik Andersson, William C. de Groat, Kevin T. McVary, Tom F. Lue, Mario Maggi, Claus G. Roehrborn, Jean‐Jacques Wyndaele, Thomas Melby, Lars Viktrup	2011	177
5	<p>Nerve Growth Factor Signaling and Its Contribution to Pain</p> Journal of Pain Research ·Philip A. Barker, Patrick W. Mantyh, Lars Arendt‐Nielsen, Lars Viktrup, Leslie Tive	2020	163
6	Efficacy and Safety of Tadalafil Once Daily in the Treatment of Men With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: Results of an International Randomized, Double-Blind, Placebo-Controlled Trial European Urology ·Hartmut Porst, Edward D. Kim, Adolfo Casabé, Vincenzo Mirone, Roberta J. Secrest, Lei Xu, David P. Sundin, Lars Viktrup	2011	137
7	Effect of Tanezumab on Joint Pain, Physical Function, and Patient Global Assessment of Osteoarthritis Among Patients With Osteoarthritis of the Hip or Knee JAMA ·Thomas J. Schnitzer, Richard Easton, Shirley Pang, Dennis J. Levinson, Glenn C. Pixton, Lars Viktrup, Isabelle Davignon, M. Brown, Christine R. West, Kenneth M. Verburg	2019	136
8	The risk of stress incontinence 5 years after first delivery American Journal of Obstetrics and Gynecology ·Lars Viktrup, Gunnar Lose	2001	127
9	The Mechanism of Action of Phosphodiesterase Type 5 Inhibitors in the Treatment of Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia European Urology ·François Giuliano, Stefan Ückert, Mario Maggi, Lori A. Birder, J. Kissel, Lars Viktrup	2012	126
10	Risk of Stress Urinary Incontinence Twelve Years After the First Pregnancy and Delivery Obstetrics and Gynecology ·Lars Viktrup, Guri Rørtveit, Gunnar Lose	2006	117
11	Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period Annals of the Rheumatic Diseases ·Francis Bérenbaum, Francisco J. Blanco, Ali Guermazi, Kenji Miki, Takaharu Yamabe, Lars Viktrup, Rod Junor, William Carey, Mark T. Brown, Christine R. West, Kenneth M. Verburg	2020	111
12	Nerve growth factor antibody for the treatment of osteoarthritis pain and chronic low-back pain: mechanism of action in the context of efficacy and safety Pain ·Martin Schmelz, Patrick W. Mantyh, Anne‐Marie Malfait, John T. Farrar, Tony L. Yaksh, Leslie Tive, Lars Viktrup	2019	94
13	The risk of lower urinary tract symptoms five years after the first delivery* Neurourology and Urodynamics ·Lars Viktrup	2001	92
14	A retrospective pooled analysis of duloxetine safety in 23 983 subjects Current Medical Research and Opinion ·James Gahimer, Joachim Wernicke, Ilker Yalcin, Melissa J. Ossanna, Meghan Wulster-Radcliffe, Lars Viktrup	2006	83
15	Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a 1‐year, open‐label extension study British Journal of Urology ·Craig F. Donatucci, Gerald Brock, Evan R. Goldfischer, Peter Pommerville, Albert Elion‐Mboussa, J. Kissel, Lars Viktrup	2011	78
16	Coexisting lower urinary tract symptoms and erectile dysfunction: a systematic review of epidemiological data International Journal of Clinical Practice ·A D Seftel, Jean de la Rosette, Julie Birt, Victoria Porter, Victoria Zarotsky, Lars Viktrup	2012	78
17	Tadalafil once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A randomized placebo‐ and tamsulosin‐controlled 12‐week study in Asian men International Journal of Urology ·Osamu Yokoyama, Masaki Yoshida, Sae Chul Kim, Chii‐Jye Wang, Takeshi Imaoka, Yoji Morisaki, Lars Viktrup	2012	76
18	Construct validation of patient global impression of severity (PGI-S) and improvement (PGI-I) questionnaires in the treatment of men with lower urinary tract symptoms secondary to benign prostatic hyperplasia BMC Urology ·Lars Viktrup, Risa P. Hayes, Ping Wang, Wei Shen	2012	75
19	Efficacy and Safety of the Coadministration of Tadalafil Once Daily with Finasteride for 6 Months in Men with Lower Urinary Tract Symptoms and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia The Journal of Urology ·Adolfo Casabé, Claus G. Roehrborn, L. Da Pozzo, Sebastian Zepeda, Ralph J. Henderson, Sebastian Sorsaburu, Carsten Henneges, David G. Wong, Lars Viktrup	2013	74
20	Serotonin and noradrenaline involvement in urinary incontinence, depression and pain: scientific basis for overlapping clinical efficacy from a single drug, duloxetine International Journal of Clinical Practice ·Karl B. Thor, Michael Kirby, Lars Viktrup	2007	68

About Lars Viktrup

Lars Viktrup is a scholar working on Urology, Rheumatology, Psychiatry and Mental health, Endocrinology, Diabetes and Metabolism and Pharmacology, having authored 151 papers that have together received 4.6k indexed citations. Recurring topics across this work include Urinary Bladder and Prostate Research (60 papers), Pelvic floor disorders treatments (43 papers), Hormonal and reproductive studies (32 papers), Osteoarthritis Treatment and Mechanisms (28 papers), Sexual function and dysfunction studies (24 papers), Inflammatory mediators and NSAID effects (21 papers), Musculoskeletal pain and rehabilitation (17 papers) and Prostate Cancer Diagnosis and Treatment (16 papers). The work is most often cited by research in Urology (2.4k citations), Rheumatology (2.1k citations), Psychiatry and Mental health (1.4k citations), Endocrinology, Diabetes and Metabolism (1.2k citations) and Pharmacology (682 citations). Lars Viktrup has collaborated with scholars based in United States, United Kingdom and Denmark. Frequent co-authors include Gunnar Lose, Claus G. Roehrborn, Albert Elion‐Mboussa, Kevin T. McVary, François Giuliano, Lei Xu, Ilker Yalcin, David A. Cox, Leslie Tive and Vincenzo Mirone. Their work appears in journals such as The Journal of Urology, Current Medical Research and Opinion, British Journal of Urology, European Urology and Osteoarthritis and Cartilage.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact